loadpatents
name:-0.012129068374634
name:-0.0034260749816895
name:-0.0020811557769775
Zaman; Noreen Tasneem Patent Filings

Zaman; Noreen Tasneem

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zaman; Noreen Tasneem.The latest application filed is for "pharmaceutical compositions and administrations thereof".

Company Profile
1.2.14
  • Zaman; Noreen Tasneem - Acton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Compositions And Administrations Thereof
App 20190038615 - Van Goor; Fredrick F. ;   et al.
2019-02-07
Pharmaceutical Compositions And Administrations Thereof
App 20180153874 - Van Goor; Fredrick F. ;   et al.
2018-06-07
Pharmaceutical Compositions And Administrations Thereof
App 20160067239 - Van Goor; Fredrick F. ;   et al.
2016-03-10
Pharmaceutical Compositions and Administrations Thereof
App 20160022664 - Van Goor; Fredrick F. ;   et al.
2016-01-28
Pharmaceutical Compositions and Administrations Thereof
App 20160022665 - Van Goor; Fredrick F. ;   et al.
2016-01-28
Pharmaceutical Compositions And Administrations Thereof
App 20150164883 - Van Goor; Fredrick F. ;   et al.
2015-06-18
Pharmaceutical Compositions and Administrations Thereof
App 20150164881 - Van Goor; Fredrick F. ;   et al.
2015-06-18
Pharmaceutical Compositions And Administrations Thereof
App 20150141459 - Van Goor; Fredrick F. ;   et al.
2015-05-21
Formulations Of (r)-1-(2,2-difluorobenzo[d] [1,3] Dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpro- Pan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide
App 20140094499 - ALARGOVA; ROSSITZA GUEORGUIEVA ;   et al.
2014-04-03
Pharmaceutical Compositions And Administrations Thereof
App 20130338188 - Van Goor; Fredrick F. ;   et al.
2013-12-19
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpro- pan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
Grant 8,563,593 - Alargova , et al. October 22, 2
2013-10-22
Pharmaceutical Compositions And Administrations Thereof
App 20130158071 - Van Goor; Fredrick F. ;   et al.
2013-06-20
Pharmaceutical Compositions And Administrations Thereof
App 20130143919 - Van Goor; Fredrick F. ;   et al.
2013-06-06
Pharmaceutical Compositions And Administrations Thereof
App 20130131107 - Van Goor; Fredrick F. ;   et al.
2013-05-23
Formulations Of (r)-1-(2,2-difluorobenzo[d] [1,3] Dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpro- Pan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide
App 20120015999 - Alargova; Rossitza Gueorguieva ;   et al.
2012-01-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed